A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of multiple doses of isavuconazole on the
pharmacokinetics of Repaglinide and possible metabolites after single dose administration. In
addition, this study will assess the effect of multiple doses of isavuconazole on the
pharmacokinetics of caffeine and possible metabolites after single dose administration.
Safety and tolerability of isavuconazole alone and in combination with Repaglinide or in
combination with caffeine will be assessed.